Cell signaling factors date back to early man and were, in fact, post-digestion, low molecular weight peptides derived from eating certain mammalian organs for any number of perceived medicinal benefits depending on the organ consumed. There are dramatic illustrations of this concept from movies such as Kevin Costner’s “Dancing With Wolves” where the plains indians ate fresh bison heart after a bison kill for energy to Mel Gibson’s “Apocalypto” showing a pre-Columbian Yucatan hunting party kill a pig and pass around different organs, fresh from the kill, to different members of the hunting party for perceived medicinal needs including the heart, the liver and the testes from the pig. In modern times, this same concept began with the use of a pig-liver derived, low molecular weight, injectable extract called Kutapressin in the 1930’s and was used for treating inflammatory skin diseases and shingles through the 1950’s and into the 1980’s specifically for Chronic Fatigue Syndrome (see Steinbach et al “Clin. Inf. Dis”, Vol 18, Supple I, S114, 1994). Studies by Ablashi out of NCI showed that Kutapressin can inhibit HHV-6 (see Ablashi at al, “Clin. Inf. Dis”, Vol 18, Supple I, S113, 1994), which makes sense as it was long known to treat another herpes virus causing shingles (chicken pox). Pope Pius XII was treated by his physician with low molecular weight, protein extracts derived from adrenal and thymus tissue of mammals in the 1950’s on his death bed and lived another four years.
The Cheney Institute now offers transdermal Cell Signaling Factors (CSF’s) to the broader public and specifically Chronic Fatigue Syndrome patients, derived from low molecular weight, protein extracts from an organic porcine source in Canada whose manufacturing standards meet FDA criteria for food processing. The Cheney Clinic tested these various transdermally applied, organ and plant derived peptides using real-time echocardiographic changes induced by these CSF pastes to prove they were both bioactive and improved cardiac cellular energetics by IVRT response criteria on the cardiac echo. The Cheney Clinic has used these transdermal CSF’s successfully in CFS patients for over a decade including a prospective study of clinical outcomes in CFS over 12 months of treatment in 2007. They are typically applied to the skin daily for the less potent CSF’s to twice weekly for the more potent CSF’s, at least to start. PLEASE NOTE THAT THESE TRANSDERMAL CSF’S HAVE NOT BEEN APPROVED BY ANY GOVERNMENTAL AGENCY NOR PROVEN TO TREAT ANY KNOWN DISEASE OR CONDITION. THEY DO NOT WORK IN ALL CASES OF CFS AND IN SOME CASES, CAN MAKE CFS WORSE. HOWEVER, THEY CAN BE WELL TOLERATED AS WELL AS HELPFUL IN PATIENTS WHO ARE TRADITIONALLY INTOLERANT TO MANY OTHER THERAPIES.
For more details on ordering these transdermal peptides and how each should be used and for what reasons, contact Dixie at the Cheney Institute at 828-620-1113 or firstname.lastname@example.org.
All CSF’s are mixed with Emu oil to assist in transdermal use and also mixed with Vitamin E as a preservative.
Currently available transdermal CSF’s include:
- Catabolic derived from Porcine Heart — Daytime energy
- Anabolic derived from Porcine Liver — Nighttime sleep, detoxification and anti-viral effects
- MTF derived from Porcine Placenta (rich in stem cells) – Nighttime healing and redox support – our most potent CSF
- Brain derived from Porcine Brain – Seizures and CNS anti-inflammation
- CBD oil derived from Hemp – anti-inflammation and seizures – often added with Brain to the skin